What could rein in rising drug prices? Project Japan sought to find out.
The American Medical Association and the American Society of Addiction Medicine have developed a new way to reimburse physicians who treat patients for opioid use disorder.
The FDA is encouraging drugmakers to conduct fewer clinical trials on certain proposed medication-assisted therapies for opioid use disorder, saying a streamlined approach will help patients access treatment quicker.
New data show that the number of opioid painkiller prescriptions filled in the U.S. experienced their biggest drop in 25 years. The decline comes amid increasing legal restrictions and public awareness of the dangers of addiction.
Highmark Health, a Pittsburgh-based Blues plan, has reached a value-based drug-pricing contract with AstraZeneca for Symbicort, which is used to treat asthma and other chronic lung diseases.
A treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It's the biggest win so far for immunotherapy, which has had much of its success in less common cancers.
The Drug Enforcement Administration has raised production quotas for injectable opioid manufacturers, but relief isn't expected until summer.
Generic-drug manufacturers, which source most of their active ingredients from China and India, could be hit the hardest by President Donald Trump's proposed tariffs, experts said.
A federal judge with an audacious plan to settle hundreds of lawsuits filed by local governments against the drug industry over the destruction wrought by prescription opioid painkillers has altered his course.
A Canadian online pharmacy is expected to be fined $34 million Friday for importing counterfeit cancer drugs and other unapproved pharmaceuticals into the U.S., a sentence some call too light for such a heinous crime.
Aiming to lower what patients pay for prescriptions, CVS' new initiatives include a tool that will let pharmacists check for cheaper alternatives.
U.S. Surgeon General Dr. Jerome Adams wants more Americans to start carrying the overdose antidote naloxone to help combat the nation's opioid crisis and save lives.